419 related articles for article (PubMed ID: 19294612)
1. Nestin as a marker in the classification of adrenocortical tumors.
Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
[TBL] [Abstract][Full Text] [Related]
2. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
[TBL] [Abstract][Full Text] [Related]
5. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
7. [Adrenocortical tumors with neuroendocrine differentiation].
Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
12. Myxoid adrenal cortical neoplasms.
Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.
Rotondo F; Kovacs K; Horvath E; Bell CD; Lloyd RV; Scheithauer BW
Acta Neuropathol; 2006 Mar; 111(3):272-7. PubMed ID: 16538520
[TBL] [Abstract][Full Text] [Related]
14. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
15. Histologic and immunohistochemical classification of 41 bovine adrenal gland neoplasms.
Grossi AB; Leifsson PS; Jensen HE; Vainer B; Iburg T
Vet Pathol; 2013 May; 50(3):534-42. PubMed ID: 23242804
[TBL] [Abstract][Full Text] [Related]
16. Expression of nestin mRNA is a differentiation marker in thyroid tumors.
Yamada H; Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Watanabe M; Iwatani Y; Miyauchi A
Cancer Lett; 2009 Jul; 280(1):61-4. PubMed ID: 19268442
[TBL] [Abstract][Full Text] [Related]
17. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395
[TBL] [Abstract][Full Text] [Related]
19. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor GATA-4 is a marker of anaplasia in adrenocortical neoplasms of the domestic ferret (Mustela putorius furo).
Peterson RA; Kiupel M; Bielinska M; Kiiveri S; Heikinheimo M; Capen CC; Wilson DB
Vet Pathol; 2004 Jul; 41(4):446-9. PubMed ID: 15232151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
